Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH)

FDA Applications

Note: This list only includes applications that have been responded to by the FDA.

ApplicationProduct NameActive IngredientFormStrengthStatus
NDA021711 - LANTHEUS MEDCL
ABLAVARGADOFOSVESET TRISODIUMSOLUTION;INTRAVENOUS3660MG/15ML (244MG/ML)Discontinued
ABLAVARGADOFOSVESET TRISODIUMSOLUTION;INTRAVENOUS2440MG/10ML (244MG/ML)Discontinued
NDA021064 - LANTHEUS MEDCL
DEFINITYPERFLUTRENINJECTABLE;INTRAVENOUS13.04MG/2ML (6.52MG/ML)Prescription
DEFINITY RTPERFLUTRENINJECTABLE;INTRAVENOUS13.04MG/2ML (6.52MG/ML)Prescription
NDA020256 - LANTHEUS MEDCL
NEUROLITETECHNETIUM TC-99M BICISATE KITINJECTABLE;INJECTIONN/APrescription
NDA019785 - LANTHEUS MEDCL
CARDIOLITETECHNETIUM TC-99M SESTAMIBI KITINJECTABLE;INJECTIONN/APrescription
MIRALUMATECHNETIUM TC-99M SESTAMIBI KITINJECTABLE;INJECTIONN/ADiscontinued
NDA017806 - LANTHEUS MEDCL
THALLOUS CHLORIDE TL 201THALLOUS CHLORIDE TL-201INJECTABLE;INTRAVENOUS2mCi/MLDiscontinued
THALLOUS CHLORIDE TL 201THALLOUS CHLORIDE TL-201INJECTABLE;INJECTION1mCi/MLDiscontinued
NDA017771 - LANTHEUS MEDCL
TECHNELITETECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATORSOLUTION;INTRAVENOUS0.0083-2.7 CI/GENERATORDiscontinued
TECHNELITETECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATORSOLUTION;INTRAVENOUS1-20 CI/GENERATORPrescription
NDA017478 - LANTHEUS MEDCL
GALLIUM CITRATE GA 67GALLIUM CITRATE GA-67INJECTABLE;INJECTION2mCi/MLDiscontinued
NDA017284 - LANTHEUS MEDCL
XENON XE 133XENON XE-133GAS;INHALATION10mCi/VIALPrescription
XENON XE 133XENON XE-133GAS;INHALATION20mCi/VIALPrescription
NDA017283 - LANTHEUS MEDCL
XENON XE 133XENON XE-133INJECTABLE;INJECTION6.3mCi/MLDiscontinued